Pathopharmacology of excessive hemorrhage in mifepristone abortions

被引:10
|
作者
Miech, Ralph P. [1 ]
机构
[1] Brown Univ, Warren Alpert Med Sch, Dept Mol Pharmacol, Providence, RI 02912 USA
关键词
abortion; glucocorticoids; hemorrhage; mifepristone; nitric oxide;
D O I
10.1345/aph.1K351
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To explain a pathopharmacologic mechanism that initiates an increase in hemorrhage following medical abortions with mifepristone. DATA SOURCES: MEDLINE, PubMed, and Google Scholar databases were searched (1990-July 2007). Key search terms were mifepristone, RU486, medical abortion hemorrhage, bleeding, inflammation, innate immune system, phagocytes, macrocytes, cytokines, interleukins, and nitric oxide. STUDY SELECTION AND DATA EXTRACTION: All articles identified from the data sources were evaluated and all information deemed relevant was included for the information related to the development of the understanding of the pathopharmacology of mifepristone as the initiating cause of increased hemorrhage in medical abortions. Mifepristone's blockade of glucocorticoid receptors, prolonged generation of nitric oxide (NO), and postabortion vasodilatation of uterine vasculature by NO that favors excessive hemorrhage were the criteria used to determine whether information was relevant for inclusion. DATA SYNTHESIS: Inescapable bacterial contamination of the decidua accompanies spontaneous, surgical, and mifepristone abortions and is routinely overcome by activation of the innate immune system. The combination of the induction of NO synthase (NOS) and local production of NO is one of the key features of the activation of the innate immune system's phagocytes. NO is a potent vasoclilator and is associated with menstrual menorrhagia. Glucocorticoids prevent the overproduction of NOS and NO and thereby contribute to the control of hemorrhage in the postabortion phase. CONCLUSIONS: Blockade of the glucocorticoid receptors by mifepristone can result in an excess of NO that is theorized to be the cause of excessive hemorrhage seen in mifepristone abortions.
引用
收藏
页码:2002 / 2007
页数:6
相关论文
共 50 条
  • [1] Safety of mifepristone abortions in clinical use
    Henderson, JT
    Hwang, AC
    Harper, CC
    Stewart, FH
    CONTRACEPTION, 2005, 72 (03) : 175 - +
  • [2] Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol
    Wiebe, E
    Dunn, S
    Guilbert, E
    Jacot, F
    Lugtig, L
    OBSTETRICS AND GYNECOLOGY, 2002, 99 (05): : 813 - 819
  • [3] Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol
    Wiebe, E
    Dunn, S
    Guilbert, E
    Jacot, F
    Lugtig, L
    JOURNAL OF FAMILY PRACTICE, 2002, 51 (03): : 264 - 264
  • [4] ORAL PROSTAGLANDIN PROVES EFFECTIVE AS SUPPLEMENT TO MIFEPRISTONE FOR NONSURGICAL ABORTIONS IN FRANCE
    HOLLANDER, D
    FAMILY PLANNING PERSPECTIVES, 1993, 25 (05): : 235 - 236
  • [5] EXCESSIVE PRIMARY POSTPARTUM HEMORRHAGE
    Negura, A.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (03): : 568 - 572
  • [6] Septic shock after medical abortions with mifepristone (Mifeprex, RU 486) and misoprostol
    Murray, S
    Wooltorton, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (05) : 485 - 485
  • [7] THE FREQUENCY OF TRANSPLACENTAL HEMORRHAGE IN PATIENTS WITH THREATENED ABORTIONS
    KULLER, JA
    LAIFER, SA
    PORTNEY, DL
    RULIN, MC
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1994, 37 (04) : 229 - 231
  • [8] Efficacy of Single Dose of Mifepristone Combined with Two Doses of Misoprostol in Early Medical Abortions
    Aarti Umranikar
    Sameer Umranikar
    Journal of Reproduction and Contraception, 2010, (01) : 35 - 40
  • [9] EVALUATING FETOMATERNAL HEMORRHAGE BY ALPHAFETOPROTEIN AND KLEIHAUER FOLLOWING THERAPEUTIC ABORTIONS
    HAY, DL
    HORACEK, I
    PAULL, J
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1982, 20 (01) : 1 - 3
  • [10] PREDICTING EXCESSIVE HEMORRHAGE IN AIS-PSIF
    Thompson, M. E.
    Hansen, J.
    McFann, K.
    McNair, B.
    Miller, N.
    ANESTHESIA AND ANALGESIA, 2013, 116 : 255 - 255